Schwartzentruber, Aurelie
Boschian, Camilla
Lopes, Fernanda Martins
Myszczynska, Monika A.
New, Elizabeth J.
Beyrath, Julien
Smeitink, Jan
Ferraiuolo, Laura
Mortiboys, Heather
Funding for this research was provided by:
Australian Research Council (DP180101897)
Horizon 2020 Framework Programme (SysMedPD)
ZonMW PMRare (113302003)
Parkinson's UK (K1506, F1301)
Wellcome Trust (SBF002/1142)
Celgene
Article History
Received: 2 March 2020
Accepted: 19 August 2020
First Online: 23 September 2020
Competing interests
: JS is the founding chief executive officer of Khondrion. JB is the chief scientific officer of Khondrion. All other authors have no competing interests to declare.